Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2153207013 | Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2160838018 | Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | est un(e) (attribut) | Propranolol+diuretic (product) | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | a pour principe actif (attribut) | Diuretic (substance) | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | a pour principe actif (attribut) | Propranolol (substance) | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | est un(e) (attribut) | Propranolol hydrochloride + bendrofluazide (product) | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | a pour principe actif (attribut) | Propranolol hydrochloride | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | a pour principe actif (attribut) | Bendrofluazide - chemical (substance) | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | a pour principe actif (attribut) | Bendroflumethiazide (substance) | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | a une forme pharmaceutique (attribut) | Capsule | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | est un(e) (attribut) | Product containing bendroflumethiazide and propranolol (medicinal product) | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | a une forme pharmaceutique (attribut) | Oral capsule | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | a une forme pharmaceutique (attribut) | Modified-release oral capsule | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | est un(e) (attribut) | Propranolol-containing product in oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR